Insulin detemir Subcutaneous and Pembrolizumab Intravenous
Determining the interaction of Insulin detemir Subcutaneous and Pembrolizumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin detemir
Brand name: Levemir, Levemir FlexPen, Levemir PenFill, Levemir InnoLet, Levemir FlexTouch
Synonyms: Insulin detemir, Insulin Detemir
Generic Name: pembrolizumab
Brand name: Keytruda
Synonyms: Pembrolizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin detemir Subcutaneous-Pemetrexed
- Insulin detemir Subcutaneous-Pemetrexed Disodium
- Insulin detemir Subcutaneous-Pemetrexed Intravenous
- Insulin detemir Subcutaneous-Pemoline
- Insulin detemir Subcutaneous-Penbutolol
- Insulin detemir Subcutaneous-Penciclovir
- Pembrolizumab Intravenous-Insulin glargine
- Pembrolizumab Intravenous-Insulin Glargine (U-100) Cartridge Systems and Pens
- Pembrolizumab Intravenous-Insulin Glargine (U-100) Vials
- Pembrolizumab Intravenous-Insulin Glargine (U-300) Pens
- Pembrolizumab Intravenous-Insulin glargine and lixisenatide
- Pembrolizumab Intravenous-Insulin glargine and lixisenatide Subcutaneous